Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 595,261 | 447,801 | 380,095 | 387,628 | 341,572 |
| Cost of Goods | 95,990 | 81,789 | 73,522 | 76,543 | 71,173 |
| Gross Profit | 499,271 | 366,012 | 306,573 | 311,085 | 270,399 |
| Operating Expenses | 818,976 | 738,059 | 775,717 | 749,985 | 709,971 |
| Operating Income | -318,715 | -371,258 | -468,622 | -438,357 | -439,399 |
| Other Income | -48,748 | 34,319 | 37,657 | -112,881 | -118,186 |
| Pre-tax Income | -367,463 | -336,939 | -430,965 | -551,238 | -557,585 |
| Income Tax | 13,674 | 11,492 | 14,370 | 6,318 | 8,141 |
| Net Income Continuous | -381,137 | -348,431 | -445,335 | -557,556 | -565,726 |
| Net Income | $-381,137 | $-348,431 | $-445,335 | $-557,556 | $-565,726 |
| EPS Basic Total Ops | -3.64 | -3.34 | -4.29 | -5.39 | -5.50 |
| EPS Basic Continuous Ops | -3.64 | -3.34 | -4.29 | -5.39 | -5.50 |
| EPS Diluted Total Ops | -3.64 | -3.34 | -4.29 | -5.39 | -5.50 |
| EPS Diluted Continuous Ops | -3.64 | -3.34 | -4.29 | -5.39 | -5.50 |
| EBITDA(a) | $-296,380 | $-351,247 | $-450,606 | $-422,156 | $-423,938 |